ONLY $9.90 DELIVERY INFO

Close Notification

Your cart does not contain any items

Psychedelic Capitalism

Jamie Brownlee Kevin Walby

$52.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Fernwood Publishing Co Ltd
31 July 2025
Psychedelics have long been sanctioned as dangerous substances. Today, psychedelics are enjoying a new found appeal, even being idealized as wonder drugs. As part of the so-called psychedelic renaissance, reports abound about the benefits of these substances for remedying individual mental health issues and bringing about social change.

Offering a critical view of these developments, Psychedelic Capitalism locates this renaissance in the context of corporate capture, medicalization, and the war on drugs. Wealthy entrepreneurs are investing billions in the psychedelics industry. Biotechnology firms are racing to capture intellectual property and monopolize psychedelic supply chains. Venture capitalists are leveraging the prospects of a lucrative mass market. Together, these actors are appropriating Indigenous knowledge and claiming ownership over substances that have been in the public domain for centuries.

Brownlee and Walby ask if corporations and the medical establishment are suited to steward the mainstreaming of psychedelics, raising concerns with how the psychedelic renaissance is entrenching systems of inequality, limiting access and affordability, and increasing the reach of drug war surveillance and criminalization. Interrogating the consequences of psychedelic capitalism, the authors point to what could be gained from a just and equitable psychedelic future rooted in the public interest.
By:   ,
Imprint:   Fernwood Publishing Co Ltd
Country of Publication:   Canada
Dimensions:   Height: 23mm,  Width: 15mm,  Spine: 1mm
Weight:   397g
ISBN:   9781773637310
ISBN 10:   1773637312
Pages:   256
Publication Date:  
Audience:   Professional and scholarly ,  College/higher education ,  Undergraduate ,  Further / Higher Education
Format:   Paperback
Publisher's Status:   Active

Jamie Brownlee teaches at Carleton University in the areas of Canadian and international political economy, corporate crime, environmental policy, and climate change. He is the author of Ruling Canada: Corporate Cohesion and Democracy and Academia, Inc.: How Corporatization Is Transforming Canadian Universities. Kevin Walby is a professor of criminal justice at the University of Winnipeg. He is co-author of Police Funding, Dark Money, and the Greedy Institution. He is also the director of the Centre for Access to Information and Justice and co-editor of the Journal of Prisoners on Prisons.

Reviews for Psychedelic Capitalism

Psychedelic Capitalism provides an incisively critical analysis of many of the key themes that arise from the renewed interest and legitimacy of psychedelic drugs and substances. In clear and concise prose, Brownlee and Walby weave a cogent and compelling story based on many disparate critical voices and perspectives calling for a closer examination of the often-unbridled enthusiasm for the current psychedelic renaissance. They call for people in--or entering--the expanding field of psychedelic science and therapeutics to critically consider the socio-political and economic foundations of what's driving the popularization of this (re)emergent area of research and practice. The authors have done an excellent job in taking on this task through a penetrating and dispassionate narrative.--Kenneth Tupper, adjunct professor, School of Child and Youth Care, University of Victoria Psychedelic Capitalism offers a timely and incisive analysis of the rapidly evolving psychedelic terrain. Brownlee and Walby expose where the corporate capture trip is headed through hasty medicalization, commercialization, psychedelic tourism, Big Tech, Big Pharma, and intellectual property practices. The book wakes our senses to how powerful interests are reshaping the meaning of psychedelics, largely to the detriment of Indigenous practices, recreational uses, and communities excluded from the benefits of the new psychedelic frontier.--Shelley Marshall, adjunct professor, College of Nursing, University of Manitoba and harm reduction programme organizer


See Also